Each year we dedicate on average 20% of our revenue to product development as well as projects that increase the efficiency of our manufacturing operations. By maintaining a high commitment to R&D, we are able to fuel the continuous development of new technologies and satisfy the clinical and economic needs of our customers.
As a result of our commitment to innovation, we have a portfolio of over 650 medical devices and a pipeline filled with the next generation of breakthrough technologies for minimally invasive surgery. Our advanced technologies enable surgeons to provide their patients with enhanced clinical outcomes.
